Skip to content
Advertisement

Former biotech CEO Martin Shkreli, center, leaves federal court with his attorney Benjamin Brafman, left, Thursday, July 27, 2017, in New York. Brafman told the jury during closing arguments that his client annoyed some of his investors but ultimately rewarded them by starting a drug company that doubled or tripled their money. (AP Photo/Julie Jacobson)

Former biotech CEO Martin Shkreli, center, leaves federal court with his attorney Benjamin Brafman, left, Thursday, July 27, 2017, in New York. Brafman told the jury during closing arguments that his client annoyed some of his investors but ultimately rewarded them by starting a drug company that doubled or tripled their money. (AP Photo/Julie Jacobson)

Featured Photo Galleries